Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non–small-cell lung cancer: a meta-analysis

MK Gould, WG Kuschner, CE Rydzak… - Annals of internal …, 2003 - acpjournals.org
Purpose: To compare the diagnostic accuracy of computed tomography (CT) and positron
emission tomography (PET) with 18-fluorodeoxyglucose (FDG) for mediastinal staging in …

Noninvasive staging of non-small cell lung cancer: a review of the current evidence

EM Toloza, L Harpole, DC McCrory - Chest, 2003 - Elsevier
Study objectives To determine the test performance characteristics of CT scanning, positron
emission tomography (PET) scanning, MRI, and endoscopic ultrasound (EUS) for staging …

Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice …

GA Silvestri, AV Gonzalez, MA Jantz, ML Margolis… - Chest, 2013 - Elsevier
Background Correctly staging lung cancer is important because the treatment options and
prognosis differ significantly by stage. Several noninvasive imaging studies and invasive …

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre …

H Van Tinteren, OS Hoekstra, EF Smit… - The Lancet, 2002 - thelancet.com
Background Up to 50% of curative surgery for suspected non-small-cell lung cancer is
unsuccessful. Accuracy of positron emission tomography (PET) with 18-fluorodeoxyglucose …

Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines

GA Silvestri, MK Gould, ML Margolis, LT Tanoue… - Chest, 2007 - Elsevier
Background Correctly staging lung cancer is important because the treatment options and
the prognosis differ significantly by stage. Several noninvasive imaging studies including …

Molecular imaging and its biological applications

ME Phelps - Eur J Nucl Med Mol Imaging, 2004 - Springer
This book is written as both a text and a reference book. It contains numerous images from
the biological sciences and clinical practice, tables, graphs, and fig ures, as well as …

PET imaging in oncology

R Bar-Shalom, AY Valdivia, MD Blaufox - Seminars in nuclear medicine, 2000 - Elsevier
The role of positron emission tomography (PET) during the past decade has evolved rapidly
from a pure research tool to a methodology of enormous clinical potential. Perhaps the most …

FDG-PET for clinical use: results of the 3rd German Interdisciplinary Consensus Conference," Onko-PET III", 21 July and 19 September 2000

SN Reske, J Kotzerke - European journal of nuclear medicine, 2001 - Springer
Positron emission tomography (PET) is the most powerful molecular imaging technique
currently available for clinical use. Because deranged tumour metabolism is a common …

Management of bone metastases in cancer: a review

G Selvaggi, GV Scagliotti - Critical reviews in oncology/hematology, 2005 - Elsevier
The presence of bone metastases is indicative of disseminated disease and typically
indicates a short-term prognosis in cancer patients. Palliation of symptoms is the primary …

Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer

Ö Birim, AP Kappetein, T Stijnen… - The Annals of thoracic …, 2005 - Elsevier
A systematic review was undertaken to select studies that compared the accuracy of 2-[18F]-
fluoro-2-deoxy-D-glucose positron emission tomography with computed tomographic …